Fibrobiologics

IN THE PRESS

Lone Star Bio

FibroBiologics Files 2023 Form 10-K Annual Report

February 29, 2024

·

1 min read

Lone Star Bio

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

February 20, 2024

·

6 min read

Drug Development

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

February 13, 2024

·

5 min read

Lone Star Bio

FibroBiologics Announces Three United States Patents for Fibroblast Technology

February 8, 2024

·

4 min read

Lone Star Bio

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

February 6, 2024

·

3 min read

Deals

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG

January 31, 2024

·

3 min read

Lone Star Bio

FibroBiologics Announces Anticipated Listing Day

January 25, 2024

·

4 min read

Lone Star Bio

FibroBiologics to Present at Biotech Showcase 2024

January 4, 2024

·

3 min read

Lone Star Bio

FibroBiologics to Host Investor Day

December 7, 2023

·

2 min read

Lone Star Bio

FibroBiologics to Provide Company Update at Upcoming Conferences

September 14, 2023

·

2 min read

JOBS